跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
王 淵宏
副教授
,
臨床醫學研究所
合聘副教授
,
國際醫學研究碩博士學位學程
醫學研究員
,
衛生福利部雙和醫院
成員
,
臺北醫學大學胸腔醫學研究中心
https://orcid.org/0000-0001-5570-2622
電子郵件
d508091002
tmu.edu
tw
h-index
2696
引文
29
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2025
每年研究成果
概覽
指紋
網路
專案
(13)
研究成果
(121)
類似的個人檔案
(6)
指紋
查看啟用 Yuan-Hung Wang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Transitional Cell Carcinoma
50%
Meta-Analysis
49%
Diagnostic Accuracy
31%
Severe Acute Respiratory Syndrome Coronavirus 2
30%
Prostate Cancer
30%
Hazard Ratio
26%
Cohort Analysis
24%
Neoplasm
21%
COVID-19
19%
Bladder Cancer
19%
Malignant Neoplasm
19%
Lung Cancer
19%
Systematic Review
18%
End Stage Renal Disease
18%
Diagnosis
15%
Treatment Response
14%
Chronic Kidney Disease
14%
Bladder
14%
Odds Ratio
13%
Recurrent Disease
13%
Diabetes Mellitus
13%
Diagnostic Performance
13%
Disease
13%
Survivin
12%
Apoplexy
12%
Atrial Fibrillation
12%
Carotid Atherosclerosis
12%
Overall Survival
11%
Subgroup Analysis
10%
Urinary System
10%
Cigarette Smoking
9%
Metastatic Carcinoma
9%
Mediator
9%
Cancer
8%
Intestine Cancer
8%
Hemodialysis
8%
Immunohistochemistry
8%
Cytotechnology
7%
Prospective Study
7%
Prostate Specific Antigen
7%
Cohort Effect
7%
Genetic Polymorphism
7%
Proportional Hazards Model
7%
Symptom
7%
In Vitro
7%
Well Water
7%
Alzheimer's Disease
7%
Phosphodiesterase V Inhibitor
7%
Upregulation
7%
Transforming Growth Factor
6%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
100%
Cigarette Smoking
38%
Malignant Neoplasm
32%
Prostate Cancer
30%
Bladder Cancer
29%
Carotid Atherosclerosis
24%
Well Water
24%
Hemodialysis
20%
Neoplasm
19%
Cohort Study
18%
Lung Cancer
18%
Disease
17%
Recurrent Disease
15%
Carcinogenesis
14%
Glutathione
13%
Transferase
13%
Protein P53
13%
Overall Survival
13%
End Stage Renal Disease
12%
Sulfotransferase 1A1
12%
Survivin
12%
Heme Oxygenase 1
12%
Skin Cancer
12%
Secondary Hyperparathyroidism
12%
Vaccination Policy
12%
Arginine
11%
Biological Marker
11%
Chronic Disease
9%
Cardiovascular Disease
9%
Cancer Staging
9%
Methanearsonic Acid
8%
Long Term Exposure
8%
Intestine Cancer
8%
Androgen
8%
Dyslipidemia
8%
Infection
8%
Prostate Specific Antigen
7%
Chronic Kidney Failure
7%
Diabetes Mellitus
7%
Prospective Study
7%
Palmoplantar Keratoderma
7%
Disease Exacerbation
7%
Atherosclerosis
6%
Chronic Obstructive Lung Disease
6%
Cardiovascular Mortality
6%
Biochemical Recurrence
6%
Hypoxia
6%
Mouse Model
6%
Liver Cirrhosis
6%
Alzheimer's Disease
6%
Biochemistry, Genetics and Molecular Biology
Genotyping
40%
Gene Polymorphism
38%
Allele
30%
Gene Promoter
26%
Carcinogenesis
24%
Hemodialysis
18%
Heme Oxygenase
18%
Cigarette Smoking
17%
Single-Nucleotide Polymorphism
17%
Medline
15%
Methylation
14%
Cardiovascular Mortality
13%
Case-Control Study
12%
SOX2
12%
Survivin
12%
Passive Smoking
12%
Gene Expression
12%
SARS Coronavirus
12%
Interleukin 6
12%
Dyslipidemia
12%
Interleukin 8
12%
Embase
12%
Promoter Region
11%
Tumor Necrosis Factor
11%
interferon
11%
Genetic Divergence
10%
Cell Proliferation
10%
Upregulation
9%
Cancer Cell
9%
Signal Transduction
8%
Coronavirinae
8%
Mediator
8%
Smoking
8%
Messenger RNA
8%
Interleukin-6
8%
Epidermal Growth Factor Receptor
7%
XRCC1
7%
Interferon
7%
Real-Time Polymerase Chain Reaction
7%
DNA Methylation
7%
Drive
7%
B Cell
7%
Sample Size
7%
Cancer Staging
7%
Phosphotransferase
7%
Kinase
7%
Cell Survival
6%
Lifespan
6%
Inhibitor of Apoptosis
6%
Anticancer
6%
